Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: Combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage Parkinson's disease

Optimizing neuromelanin contrast in the substantia nigra and locus coeruleus using a magnetization transfer contrast prepared 3D gradient recalled echo sequence

(2020) Yu Liu et al.   NEUROIMAGE

Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain

(2019) Clifford M. Cassidy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Functional neuroanatomical review of the ventral tegmental area

(2019) Anne C. Trutti et al.   NEUROIMAGE

STrategically Acquired Gradient Echo (STAGE) imaging, part III: Technical advances and clinical applications of a rapid multi-contrast multi-parametric brain imaging method

(2019) E. Mark Haacke et al.   MAGNETIC RESONANCE IMAGING

Three-dimensional neuromelanin-sensitive magnetic resonance imaging of the substantia nigra in Parkinson's disease

(2018) S. Prasad et al.   EUROPEAN JOURNAL OF NEUROLOGY

Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes

(2018) J. Wang et al.   EUROPEAN JOURNAL OF NEUROLOGY

STrategically Acquired Gradient Echo (STAGE) imaging, part I: Creating enhanced T1 contrast and standardized susceptibility weighted imaging and quantitative susceptibility mapping

(2018) Yongsheng Chen et al.   MAGNETIC RESONANCE IMAGING

STrategically Acquired Gradient Echo (STAGE) imaging, part II: Correcting for RF inhomogeneities in estimating T1 and proton density

(2018) Yu Wang et al.   MAGNETIC RESONANCE IMAGING

Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease

(2018) Daisuke Taniguchi et al.   MOVEMENT DISORDERS

Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients

(2018) Guangwei Du et al.   MOVEMENT DISORDERS

Quantifying iron content in magnetic resonance imaging

(2018) Kiarash Ghassaban et al.   NEUROIMAGE

Specific visualization of neuromelanin-iron complex and ferric iron in the human post-mortem substantia nigra using MR relaxometry at 7T

(2018) Hansol Lee et al.   NEUROIMAGE

Movement disorder society criteria for clinically established early Parkinson's disease

(2018) Daniela Berg et al.   MOVEMENT DISORDERS

Comprehensive MRI quantification of the substantia nigra pars compacta in Parkinson’s disease

(2018) H. Takahashi et al.   EUROPEAN JOURNAL OF RADIOLOGY

Iron quantification in Parkinson's disease using an age-based threshold on susceptibility maps: The advantage of local versus entire structure iron content measurements

(2018) Sean K. Sethi et al.   MAGNETIC RESONANCE IMAGING

In vivodetection of lateral-ventral tier nigral degeneration in Parkinson's disease

(2017) Daniel E. Huddleston et al.   HUMAN BRAIN MAPPING

Neuromelanin MRI is useful for monitoring motor complications in Parkinson’s and PARK2 disease

(2017) Taku Hatano et al.   JOURNAL OF NEURAL TRANSMISSION

Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease

(2017) Philipp Mahlknecht et al.   MOVEMENT DISORDERS

In Vivo Assessment of Brainstem Depigmentation in Parkinson Disease: Potential as a Severity Marker for Multicenter Studies

(2017) Stefan T. Schwarz et al.   RADIOLOGY

Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson’s Disease

(2017) Margherita Fabbri et al.   Journal of Parkinsons Disease

Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI)

(2016) Yoonho Nam et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Parkinson's disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta

(2016) Jason Langley et al.   MOVEMENT DISORDERS

A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson’s disease

(2016) Keita Matsuura et al.   NEUROSCIENCE LETTERS

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease

(2016) Ioannis U. Isaias et al.   Frontiers in Aging Neuroscience

Quantitative Susceptibility Mapping in Parkinson's Disease

(2016) Christian Langkammer et al.   PLoS One

Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease

(2015) S. Reimão et al.   EUROPEAN JOURNAL OF NEUROLOGY

Assessing global and regional iron content in deep gray matter as a function of age using susceptibility mapping

(2015) Manju Liu et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Quantitative susceptibility mapping of the midbrain in Parkinson's disease

(2015) Guangwei Du et al.   MOVEMENT DISORDERS

Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease

(2015) Gabriel Castellanos et al.   MOVEMENT DISORDERS

A multicontrast approach for comprehensive imaging of substantia nigra

(2015) Jason Langley et al.   NEUROIMAGE

Histologic validation of locus coeruleus MRI contrast in post-mortem tissue

(2015) Noam I. Keren et al.   NEUROIMAGE

Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson’s disease

(2015) Sofia Reimão et al.   Journal of Parkinsons Disease

Substantia nigra neuromelanin magnetic resonance imaging inde novoParkinson's disease patients

(2014) S. Reimão et al.   EUROPEAN JOURNAL OF NEUROLOGY

7 tesla magnetic resonance imaging: A closer look at substantia nigra anatomy in Parkinson's disease

(2014) Stéphane Lehéricy et al.   MOVEMENT DISORDERS

An update on the connections of the ventral mesencephalic dopaminergic complex

(2014) L. Yetnikoff et al.   NEUROSCIENCE

Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease

(2013) Jeffrey H. Kordower et al.   BRAIN

Improved MR venography using quantitative susceptibility-weighted imaging

(2013) Saifeng Liu et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Visualization of nigrosome 1 and its loss in PD: Pathoanatomical correlation and in vivo 7 T MRI

(2013) A. I. Blazejewska et al.   NEUROLOGY

3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson’s disease

(2013) Kimihiro Ogisu et al.   NEURORADIOLOGY

Improving susceptibility mapping using a threshold-based K-space/image domain iterative reconstruction approach

(2012) J. Tang et al.   MAGNETIC RESONANCE IN MEDICINE

Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease

(2011) Ramachandiran Nandhagopal et al.   BRAIN

T1-Weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease

(2011) Stefan T. Schwarz et al.   MOVEMENT DISORDERS

Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature

(2010) Patrice Péran et al.   BRAIN

Susceptibility mapping as a means to visualize veins and quantify oxygen saturation

(2010) E.M. Haacke et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Handedness and motor symptom asymmetry in Parkinson's disease

(2010) M. J. Barrett et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Optimization of on-resonant magnetization transfer contrast in coronary vein MRI

(2010) Christian T. Stoeck et al.   MAGNETIC RESONANCE IN MEDICINE

Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: An approach to in vivo brain iron metabolism?

(2010) Ferdinand Schweser et al.   NEUROIMAGE

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS

UPDRS activity of daily living score as a marker of Parkinson's disease progression

(2008) Madaline B. Harrison et al.   MOVEMENT DISORDERS